Sanofi
- Country
- 🇫🇷France
- Ownership
- Public
- Employees
- 87.9K
- Market Cap
- $141.3B
- Website
- http://www.sanofi.com
- Introduction
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.
NPC Study : TAX + CIS Neoadjuvant in Patients With Loco Regionally Advanced Undifferentiated Carcinoma of Nasopharyngeal Type (UCNT)
- Conditions
- Head and Neck Neoplasms
- Interventions
- Drug: DOCETAXEL(XRP6976)
- First Posted Date
- 2009-06-09
- Last Posted Date
- 2009-06-24
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 66
- Registration Number
- NCT00916097
- Locations
- 🇹🇳
Sanofi-Aventis Administrative Office, Megrine, Tunisia
SAR407899 Single-dose in Treatment of Mild to Moderate Erectile Dysfunction
- Conditions
- Erectile Dysfunction
- Interventions
- First Posted Date
- 2009-06-04
- Last Posted Date
- 2011-05-02
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 24
- Registration Number
- NCT00914277
- Locations
- 🇫🇷
Sanofi-Aventis Administrative Office, Paris, France
Single Dose Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Evaluation of Eplivanserin in Children With Insomnia
- Conditions
- Sleep Initiation and Maintenance Disorders
- Interventions
- First Posted Date
- 2009-06-04
- Last Posted Date
- 2010-11-30
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 41
- Registration Number
- NCT00913614
- Locations
- 🇺🇸
Sanofi-Aventis Administrative Office, Bridgewater, New Jersey, United States
Efficacy and Safety of Glimepiride as Oral Anti-Diabetic (OAD) Initiation Mono-therapy in Chinese Type 2 Diabetes Mellitus (T2DM)
- First Posted Date
- 2009-05-27
- Last Posted Date
- 2012-08-08
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 391
- Registration Number
- NCT00908921
- Locations
- 🇨🇳
Sanofi-Aventis Administrative Office, Shanghai, China
LEVOS - Levofloxacin and Rifampicin Therapy in the Treatment of OsteoArticular Prothethic Infection
- First Posted Date
- 2009-05-21
- Last Posted Date
- 2011-02-07
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 10
- Registration Number
- NCT00906048
- Locations
- 🇫🇷
Sanofi-Aventis Administrative Office, Paris, France
GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in Monotherapy (GETGOAL-MONO Japan LTS)
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- Device: Pen auto-injector
- First Posted Date
- 2009-05-20
- Last Posted Date
- 2016-12-21
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 69
- Registration Number
- NCT00905255
- Locations
- 🇯🇵
Sanofi-Aventis Administrative Office, Tokyo, Japan
A Study Comparing the Effectiveness and Safety of Teriflunomide and Interferon Beta-1a in Patients With Relapsing Multiple Sclerosis
- First Posted Date
- 2009-04-17
- Last Posted Date
- 2016-06-13
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 324
- Registration Number
- NCT00883337
- Locations
- 🇧🇪
Investigational Site Number 056003, Bruxelles, Belgium
🇧🇪Investigational Site Number 056001, Gent, Belgium
🇨🇿Investigational Site Number 203004, Jihlava, Czech Republic
Dermacyd Infantile - Acceptability.
- Conditions
- Hygiene
- Interventions
- Drug: LACTIC ACID(ND)
- First Posted Date
- 2009-04-15
- Last Posted Date
- 2009-09-28
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 31
- Registration Number
- NCT00881270
- Locations
- 🇧🇷
Sanofi-Aventis Administrative Office, Sao Paulo, Brazil
Dermacyd Infantile (Lactic Acid)- Compatibility.
- Conditions
- Hygiene
- Interventions
- Drug: LACTIC ACID(ND)
- First Posted Date
- 2009-04-15
- Last Posted Date
- 2009-04-15
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 50
- Registration Number
- NCT00881374
- Locations
- 🇧🇷
Sanofi-Aventis Administrative Office, Sao Paulo, Brazil
Dermacyd Infantile (Lactic Acid) - Photo Evaluation.
- Conditions
- Hygiene
- Interventions
- Drug: LACTIC ACID(ND)
- First Posted Date
- 2009-04-15
- Last Posted Date
- 2009-04-15
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 25
- Registration Number
- NCT00881348
- Locations
- 🇧🇷
Sanofi-Aventis Administrative Office, Sao Paulo, Brazil